Scientific Opinion on the substantiation of health claims related to astaxanthin and maintenance of joints, tendons, and connective tissue (ID 1918, 1978, 3142), protection of DNA, proteins and lipids from oxidative damage (ID 1449, 3141), maintenance of visual acuity (ID 1448), maintenance of blood cholesterol concentrations and maintenance of low plasma concentrations of C-reactive protein (ID 1450) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Astaxanthin, joints, tendons, connective tissue, oxidative damage, visual acuity, blood cholesterol, C-reactive protein, health claims.
First published in the EFSA Journal
1 October 2009
Adopted
2 July 2009
Last Updated
27 November 2009. This version replaces the previous one/s.
Type
Scientific Opinion

Abstract

No abstract available

Panel members at the time of adoption

Jean-Louis Bresson, Albert Flynn, Marina Heinonen, Karin Hulshof, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Hildegard Przyrembel, Seppo Salminen, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Henk van den Berg, Hendrik van Loveren and Hans Verhagen
Panel on Dietetic Products, Nutrition and Allergies
Contact
nda [at] efsa.europa.eu
doi
10.2903/j.efsa.2009.1253
EFSA Journal 2009; 7(9):1253
On request from
European Commission